摘要
目的探讨血小板分布宽度(PDW)对短期内(治疗6个月后)房颤患者使用华法林抗凝治疗稳定性达标[达标时间百分比(TTR)]的预测价值。方法选取174例使用华法林抗凝治疗的持续性房颤患者作为研究对象,按TTR值分为达标组(TTR≥65%)54例与未达标组120例(TTR<65%),比较2组的年龄、性别、合并疾病、合并用药、血液学检查参数,同时采用Pearson相关分析检验PDW水平与TTR之间的相关性。结果2组患者合并冠心病、使用抗血小板药物、PDW异常构成比比较差异有统计学意义(P<0.05);随着PDW的升高,TTR呈下降趋势,二者呈显著负相关(r=-0.843、P<0.001)。结论PDW异常可能影响房颤患者使用华法林抗凝治疗稳定性达标,且随着PDW的升高TTR呈下降趋势。
Objective To explore the value of platelet distribution width(PDW)in predicting stability compliance of warfarin anticoagulation therapy(time in therapeutic range,TTR)in patients with atrial fibrillation in the short term(6 months after treatment).Methods According to the TTR,174 patients with persistent atrial fibrillation who underwent warfarin anticoagulation therapy were divided into two groups:achieved group(54 cases,TTR≥65%)and failed group(120 cases,TTR<65%).The age,gender,complicated diseases,combined medication and hematological parameters were compared between the two groups.The correlation between PDW level and TTR was examined using Pearson correlation analysis.Results There were significant differences between the two groups in the constituent ratios of coronary heart disease,antiplatelet drug use and abnormal PDW(P<0.05).TTR showed a downward trend with the increase of PDW,and there was a negative correlation between the two parameters(r=-0.843,P<0.001).Conclusion Abnormal PDW may affect the stability of warfarin anticoagulation therapy in patients with atrial fibrillation,and TTR tends to decline with the increase of PDW.
作者
万紫娟
罗潇
陈玲
WAN Zi-juan;LUO Xiao;CHEN ling(Health Management Center,Jiujiang First People’s Hospital,Jiujiang 332000,China;Department of Vasculocardiology,Jiujiang First People’s Hospital,Jiujiang 332000,China;Graduate School of Medicine of Nanchang University,Nanchang 330006,China)
出处
《南昌大学学报(医学版)》
2023年第4期43-47,共5页
Journal of Nanchang University:Medical Sciences
基金
江西省卫健委科技计划项目(SKJP-220217645)
九江市第一人民医院青年课题(JJSDYRMYYQNKT2021-08)。
关键词
血小板分布宽度
心房颤动
华法林
抗凝治疗稳定性
达标时间百分比
预测价值
platelet distribution width
atrial fibrillation
warfarin
stability of anticoagulation therapy
time within therapeutic range
predictive value